Telomerase Inhibitors and Activators: Pharmaceutical Importance
Open Access
- 29 March 2017
- book chapter
- Published by IntechOpen
Abstract
Telomerase Inhibitors and Activators: Pharmaceutical Importance | InTechOpen, Published on: 2017-03-29. Authors: Ayse Gul MutluKeywords
This publication has 52 references indexed in Scilit:
- Telomerase activation: A potential key modulator for human healthspan and longevityAgeing Research Reviews, 2014
- SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell LymphomasCancer Cell, 2013
- Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathwayCancer Letters, 2010
- Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinasesBioorganic & Medicinal Chemistry Letters, 2010
- Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4Bioorganic & Medicinal Chemistry Letters, 2009
- Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanismsInternational Journal of Cancer, 2009
- Pharmacological intervention strategies for affecting telomerase activity: Future prospects to treat cancer and degenerative diseaseBiochimie, 2008
- The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cellsBiochemical and Biophysical Research Communications, 2007
- Telomerase Inhibition, Telomere Shortening, and Senescence of Cancer Cells by Tea CatechinsBiochemical and Biophysical Research Communications, 1998
- Identification of a specific telomere terminal transferase activity in tetrahymena extractsCell, 1985